山东大学耳鼻喉眼学报 ›› 2021, Vol. 35 ›› Issue (1): 35-39.doi: 10.6040/j.issn.1673-3770.0.2020.133

• • 上一篇    下一篇

鼻咽癌放疗后突发性聋18例

谭玉芳,易天华   

  1. 邵阳学院附属第一医院 耳鼻咽喉头颈外科, 湖南 邵阳 422001
  • 发布日期:2021-02-01
  • 通讯作者: 谭玉芳. E-mail:tanyufang1010@163.com

Clinical characteristics and prognosis of sudden sensorineural hearing loss in post-irradiated nasopharyngeal carcinoma survivors: a report of 18 cases

TAN Yufang, YI Tianhua   

  1. Department of Otolaryngology and Head and Neck Surgery, the First Affiliated Hospital of Shaoyang University, Shaoyang 422001, Hunan, China
  • Published:2021-02-01

PDF (PC)

142

摘要： 目的 探讨鼻咽癌放疗后突发性聋(突聋)的临床特征及预后,为该类疾病的临床诊治提供依据。 方法 收集并分析18例鼻咽癌放疗后突聋患者的临床资料,包括年龄、性别、耳侧、病程、伴随症状、听力曲线类型、听力损失程度、放疗后突聋发病间隔以及听力预后。 结果 18例均为单侧发病,左侧10耳(55.56%),右侧8耳(44.44%);其中男15例(83.33%),女3例(16.67%);11耳(61.11%)伴有耳鸣,10耳(55.56%)伴有眩晕;10例(55.56%)表现为全聋型,12例(66.67%)听力损失为重度或极重度。患者治疗结束、治疗1个月和3个月后,痊愈率、显效率、有效率和无效率分别为5.56%、11.11%、16.67%、66.67%,5.56%、16.67%、16.67%、61.11%和5.56%、11.11%、22.22%、61.11%,三个时间点的疗效指标差异无统计学意义(P>0.05);患耳平均听阈改善值和对侧耳平均听阈改善值分别为(12.22±5.16)dB HL、(3.61±2.33)dB HL,(13.89±6.88)dB HL、(4.44±2.15)dB HL,(13.33±6.02)dB HL、(3.89±2.58)dB HL,组间比较差异有统计学意义(P<0.05)。 结论 鼻咽癌放疗后突聋患者听力损失较重且眩晕伴发率较高,听力曲线以全聋型为主;该类患者听力预后较差,但积极治疗后仍可改善听力预后,甚至痊愈。

关键词: 鼻咽癌, 突发性聋, 放疗, 临床特征, 预后, 听力损伤

Abstract: Objective The aim of this study is to analyze the clinical characteristics and prognosis of sudden sensorineural hearing loss(SSNHL)in post-irradiated nasopharyngeal carcinoma(NPC)survivors. Methods Medical records of 18 SSNHL patients diagnosed with NPC(NPC group)between January 2014 and May 2019 were reviewed and analyzed, including age, sex, side, treatment delay time, accompanying symptoms, hearing loss severity, audiogram pattern, interval between SSNHL and NPC, and post-treatment hearing outcome. Results Eighteen patients had unilateral hearing loss, including 10 right ears(55.56%)and 8 left ears(44.44%); the sex distribution comprised of 15 males(83.33%)and 3 females(16.67%); 11 ears(61.11%)were accompanied with tinnitus and 10 ears(55.56%)were accompanied with vertigo; 10 patients(55.56%)exhibited total deafness-type hearing loss, and 12 patients(66.67%)suffered severe or profound hearing loss. The rates of complete recovery, significant recovery, partial recovery, and no recovery after treatment, 1 month post-treatment, and 3 months post-treatment were 5.56%, 11.11%, 16.67%, 66.67%, 5.56%, 16.67%, 16.67%, 61.11%, and 5.56%, 11.11%, 22.22%, and 61.11%, respectively. No statistical difference was observed between the three groups(P>0.05). Hearing gains and contralateral hearing gains were 12.22±5.16 dB HL, 3.61±2.33 dB HL, 13.89±6.88 dB HL, 4.44±2.15 dB HL, 13.33±6.02 dB HL, and 3.89±2.58 dB HL, respectively, and hearing gains were higher than the contralateral hearing gains(P<0.05). Conclusion In this study, post-irradiated NPC survivors with SSNHL demonstrated a severe hearing loss with a high rate of accompanying vertigo, and most audiograms revealed total deafness. Although hearing recovery is poor, active treatment can still improve the hearing prognosis and can even be curative.

Key words: Nasopharyngeal carcinoma, Sudden sensorineural hearing loss, Radiotherapy, Clinical characteristics, Prognosis, Hearing loss

中图分类号: 

  • R739.6
[1] 刘寒波, 赵哲成, 文剑雪, 等. 视频眼震电图对突发性聋伴眩晕患者前庭功能的诊断价值分析[J]. 中国耳鼻咽喉颅底外科杂志, 2019, 25(3):281-284. doi:10.11798/j.issn.1007-1520.201903012. LIU Hanbo, ZHAO Zhecheng, WEN Jianxue, et al. Diagnostic value of video nystagmography for vestibular function evaluation in patients with sudden deafness and Vertigo[J]. Chinese Journal of Otorhinolaryngology-Skull Base Surgery, 2019, 25(3):281-284. doi:10.11798/j.issn.1007-1520.201903012.
[2] Schreiber BE, Agrup C, Haskard DO, et al. Sudden sensorineural hearing loss[J]. Lancet, 2010, 375(9721):1203-1211. doi:10.1016/S0140-6736(09)62071-7.
[3] 叶毅良, 卢标清. 704例突发性耳聋疗效分析[J]. 山东大学耳鼻喉眼学报, 2019, 33(5):44-47. doi:10.6040/j.issn.1673-3770.0.2019.052. YE Yiliang, LU Biaoqing. Therapeutic outcome analysis of 704 cases of sudden deafness[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2019, 33(5):44-47. doi:10.6040/j.issn.1673-3770.0.2019.052.
[4] Lin C, Lin SW, Weng SF, et al. Risk of developing sudden sensorineural hearing loss in patients with nasopharyngeal carcinoma: a population-based cohort study[J]. Head Neck, 2014, 36(2):203-208. doi:10.1002/hed.23278.
[5] Young YH, Lou PJ. Post-irradiation sudden deafness[J]. J Laryngol Otol, 1999, 113(9):815-817. doi:10.1017/s0022215100145281.
[6] 江刚, 刘永红. 以突发听力下降为首发症状的鼻咽癌一例[J]. 听力学及言语疾病杂志, 2003, 11(3):210. doi:10.3969/j.issn.1006-7299.2003.03.033.
[7] 中华耳鼻咽喉头颈外科杂志编辑委员会,中华医学会耳鼻咽喉头颈外科学分会. 突发性聋的诊断和治疗指南(2005年, 济南)[J]. 中华耳鼻咽喉头颈外科杂志, 2006, 41(5):325. doi:10.3760/j.issn:1673-0860.2006.05.003. Editorial Board of Chinese Journal of Otorhinolaryngology Head and Neck Surgery, Chinese Otorhinolaryngology Head and Neck Surgery Society of Chinese Medical Association. Guideline of diagnosis and treatment of sudden deafness[J]. Chinese Journal of Otorhinolaryngology Head and Neck Surgery, 2006, 41(5):325. doi:10.3760/j.issn:1673-0860.2006.05.003.
[8] Lee HM, Okuda KS, González FE, et al. Current perspectives on nasopharyngeal carcinoma[J]. Adv Exp Med Biol, 2019, 1164:11-34. doi:10.1007/978-3-030-22254-3_2.
[9] Chen YP, Chan ATC, Le QT, et al. Nasopharyngeal carcinoma[J]. Lancet, 2019, 394(10192):64-80. doi:10.1016/s0140-6736(19)30956-0.
[10] Young YH. Irradiated ears in nasopharyngeal carcinoma survivors: a review[J]. Laryngoscope, 2019, 129(3):637-642. doi:10.1002/lary.27303.
[11] Chi FH, Young YH. Inner ear deficits in irradiated nasopharyngeal carcinoma survivors[J]. Laryngoscope, 2015, 125(11):2565-2571. doi:10.1002/lary.25329.
[12] Young YH, Lin CY, Lou PJ, et al. Intracranial relapse of nasopharyngeal carcinoma manifested as sudden deafness[J]. Otol Neurotol, 2001, 22(3):392-396. doi:10.1097/00129492-200105000-00021.
[13] Theunissen EA, Bosma SC, Zuur CL, et al. Sensorineural hearing loss in patients with head and neck cancer after chemoradiotherapy and radiotherapy: a systematic review of the literature[J]. Head Neck, 2015, 37(2):281-292. doi:10.1002/hed.23551.
[14] Cho TY, Cheng PW, Young YH. Evolution of postirradiated sudden deafness in nasopharyngeal carcinoma survivors during the past two decades[J]. Laryngoscope, 2016, 126(9):2016-2021. doi:10.1002/lary.25893.
[15] 司楠楠, 索利敏, 靳玲, 等. 伴有眩晕或头晕重度以上突聋患者的临床疗效差异分析[J]. 中国耳鼻咽喉颅底外科杂志, 2018, 24(1):13-16. doi:10.11798/j.issn.1007-1520.201801003. SI Nannan, SUO Limin, JIN Ling, et al. Differential analyses of clinical features and efficacy of severe sudden deafness with Vertigo or dizziness[J]. Chinese Journal of Otorhinolaryngology-Skull Base Surgery, 2018, 24(1):13-16. doi:10.11798/j.issn.1007-1520.201801003.
[16] Lee HY, Kim DK, Park YH, et al. Prognostic factors for profound sudden idiopathic sensorineural hearing loss: a multicenter retrospective study[J]. Eur Arch Otorhinolaryngol, 2017, 274(1):143-149. doi:10.1007/s00405-016-4276-y.
[17] Chen WC, Jackson A, Budnick AS, et al. Sensorineural hearing loss in combined modality treatment of nasopharyngeal carcinoma[J]. Cancer, 2006, 106(4):820-829. doi:10.1002/cncr.21683.
[18] Zhu W, Chen F, Li J, et al. Dosimetric parameters associated with conductive or sensorineural hearing loss 5 years after intensity-modulated radiation therapy in nasopharyngeal carcinoma[J]. Acta Otolaryngol, 2019,139(3):263-268. doi: 10.1080/00016489.2019.1566778.
[19] Chang H, Tu TY, Wu CS, et al. Is the risk of idiopathic sudden sensorineural hearing loss higher in nasopharyngeal carcinoma than in hypopharyngeal cancer? A population-based study[J]. J Chin Med Assoc, 2020,83(9):865-869. doi: 10.1097/JCMA.0000000000000314.
[20] Chen J, Zhao Y, Zhou X, et al. Methylprednisolone use during radiotherapy extenuates hearing loss in patients with nasopharyngeal carcinoma[J]. Laryngoscope, 2016,126(1):100-103. doi: 10.1002/lary.25527.
[21] 陈平, 唐安洲, 张哲, 等. 鼻咽癌放疗后突发感音神经性聋14例临床分析[J]. 中华耳鼻咽喉头颈外科杂志, 2011, 46(9):705-708. doi:10.3760/cma.j.issn.1673-0860.2011.09.001. CHEN Ping, TANG Anzhou, ZHANG Zhe, et al. Clinical analyses of sudden sensorineural hearing loss in 14 nasopharyngeal carcinomas following radiotherapy[J]. Chinese Journal of Otorhinolaryngology Head and Neck Surgery, 2011, 46(9):705-708. doi:10.3760/cma.j.issn.1673-0860.2011.09.001.
[22] 赵俊英, 王建明. 单侧突发性聋与椎基底动脉影像学特征的相关性研究[J]. 山东大学耳鼻喉眼学报, 2019, 33(4):47-51. doi:10.6040/j.issn.1673-3770.0.2018.573. ZHAO Junying, WANG Jianming. Correlation between unilateral sudden deafness and imaging features of vertebrobasilar artery[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2019, 33(4):47-51. doi:10.6040/j.issn.1673-3770.0.2018.573.
[23] Schmitt NC, Page BR. Chemoradiation-induced hearing loss remains a major concern for head and neck cancer patients[J]. Int J Audiol, 2018, 57(Sup4):S49-S54. doi:10.1080/14992027.2017.1353710.
[25] King KA, Brewer CC. Clinical trials, ototoxicity grading scales and the audiologist's role in therapeutic decision making[J]. Int J Audiol, 2018, 57(sup4):S89-S98. doi: 10.1080/14992027.2017.1417644.
[26] Chan SL, Ng LS, Goh X, et al. Time course and clinical characterization of cisplatin-induced ototoxicity after treatment for nasopharyngeal carcinoma in a South East Asian population[J]. Head Neck, 2018, 40(7):1425-1433. doi: 10.1002/hed.25112.
[1] 张可人, 雷春燕, 张美霞. 眼睑松弛综合征伴阻塞性睡眠呼吸暂停1例[J]. 山东大学耳鼻喉眼学报, 2022, 36(5): 125-128.
[2] 姜超,周炫辰,韩杰,岳志勇. IVc期下咽癌特征分析及列线图预后模型构建[J]. 山东大学耳鼻喉眼学报, 2022, 36(4): 49-54.
[3] 程瑶,张震,杨吉,冯成敏,邓启成,张西,赵锐,朱鑫,吴俊志,刘海,邓世山. CIP2A在下咽癌中的表达及临床意义[J]. 山东大学耳鼻喉眼学报, 2022, 36(2): 40-44.
[4] 华红利,李松，陶泽璋. 人工智能在鼻咽癌诊疗中的研究进展[J]. 山东大学耳鼻喉眼学报, 2022, 36(2): 113-119.
[5] 周宇翔,,苗北平,卢永田. 首诊鼻咽癌内镜手术的治疗进展[J]. 山东大学耳鼻喉眼学报, 2021, 35(6): 108-112.
[6] 冯成敏,敬一丹,刘海,王冰. 咽喉部鳞状细胞癌细胞系[J]. 山东大学耳鼻喉眼学报, 2021, 35(6): 113-124.
[7] 刘盼,王川,赵泽祺,吴梅,徐继峰,李巍,张伟强,刘稳. 头颈部转移性透明细胞癌5例并文献复习[J]. 山东大学耳鼻喉眼学报, 2021, 35(4): 45-50.
[8] 王中卫,杨林,郭亚,孙斌,王亚利,马秀龙,任宏涛,包兴. 鼻咽癌患者miR-429、miR-200C表达与预后关系分析[J]. 山东大学耳鼻喉眼学报, 2021, 35(3): 81-86.
[9] 王莹莹,周涵,董伟达,邢光前,陈智斌,张清照,张立庆. 外耳道腺样囊性癌的远处转移及预后分析[J]. 山东大学耳鼻喉眼学报, 2021, 35(1): 1-6.
[10] 范黎,黎越,徐细明. 鼻咽癌同步放化疗前后炎性指标变化及预测价值[J]. 山东大学耳鼻喉眼学报, 2020, 34(6): 36-41.
[11] 黄俊伟,陈学军,刘宏飞,陶冶,李祖飞,陈平,张洋. 细胞周期蛋白E2在下咽癌中的表达及其意义[J]. 山东大学耳鼻喉眼学报, 2020, 34(5): 132-137.
[12] 韩继波,邹游,杨蕊,陶泽璋. Notch受体调控上皮-间质转化对鼻咽癌细胞顺铂耐药的影响[J]. 山东大学耳鼻喉眼学报, 2020, 34(4): 105-110.
[13] 周芳茗,谢艳,刘洋蒋路云. 鼻源性头痛的研究动态分析[J]. 山东大学耳鼻喉眼学报, 2020, 34(4): 130-133.
[14] 徐进敬,胡京华,吴元庆,邓毅,喻唯唯. CO2激光显微手术在喉癌前病变和早期声门型喉癌中的应用[J]. 山东大学耳鼻喉眼学报, 2020, 34(3): 129-133.
[15] 陈慧君,宋圣花,董伟达,周涵. 术前外周血纤维蛋白原水平对喉癌预后的影响[J]. 山东大学耳鼻喉眼学报, 2020, 34(2): 110-114.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
[1] 张晗,黄一飞 . 抗角膜移植排斥的研究进展[J]. 山东大学耳鼻喉眼学报, 2006, 20(1): 84 -87 .
[2] 牛善利,柴茂文,李振秀 . 鼻内镜下鼻甲成形术治疗慢性肥厚性鼻炎60例[J]. 山东大学耳鼻喉眼学报, 2006, 20(1): 16 -18 .
[3] 孟庆国,卢永田,范献良 . 杀伤细胞免疫球蛋白样受体基因多态性与鼻咽癌的关联性[J]. 山东大学耳鼻喉眼学报, 2008, 22(3): 196 -199 .
[4] 马玉起,孔祥春 . 先天性双侧下唇窦道1例[J]. 山东大学耳鼻喉眼学报, 2008, 22(3): 199 -199 .
[5] 万俐佳,鲁海涛,姜义道,刘 辉,李 琴,佘腊枝 . 改良腭咽成形术治疗阻塞性睡眠呼吸暂停综合征41例[J]. 山东大学耳鼻喉眼学报, 2008, 22(3): 204 -205 .
[6] 于青青 ,王跃建 . 硬质耳内镜的临床应用进展[J]. 山东大学耳鼻喉眼学报, 2008, 22(3): 222 -224 .
[7] 吉晓滨,邓家德,臧林泉,王 磊,谢 军 . 豚鼠变应性鼻炎模型血清组胺的测定[J]. 山东大学耳鼻喉眼学报, 2008, 22(3): 228 -230 .
[8] 向登,卢永田,孙焕吉 . 鼻内镜下修补脑脊液鼻漏19例并文献复习[J]. 山东大学耳鼻喉眼学报, 2008, 22(3): 234 -236 .
[9] 邱恩惠,李志春,方文旭 . 嗅觉障碍的中西医治疗[J]. 山东大学耳鼻喉眼学报, 2008, 22(3): 253 -257 .
[10] 殷国华,钟 笑 . 激光减容术治疗舌扁桃体肥大的远期疗效[J]. 山东大学耳鼻喉眼学报, 2008, 22(3): 280 -282 .
网站版权所有 © 2018 《山东大学耳鼻喉眼学报》编辑部　
地址：山东省济南市山大南路27号（250100）电话：+86-0531-88366912 E-mail: ebhxb@sdu.edu.cn
本系统由北京玛格泰克科技发展有限公司设计开发